The Latest Updates from ReSPECT Clinical Trials

ABTA 2024

Another great @the_abta National Conference! 🎗️🧠 A huge thank you to their organization for hosting this event and to all the patients and caregivers who came by our booth to learn about our ongoing ReSPECT Clinical Trials. For more information, please visit:...

read more

Plus is at ABTA!

Come by our booth today and tomorrow at @the_abta national conference in Chicago! Our clinical and patient advocacy team will be on-site to share educational material and answer your questions about our ReSPECT Clinical Trials. 🌟

read more

Patient Support Group HFTC

Join us at the @HeadfortheCure Patient Perspectives support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. Email courtney@headforthecure.org if you would like to attend.

read more

Childhood Cancer Awareness Month 2024

September is #ChildhoodCancerAwarenessMonth and we want to raise awareness for pediatric #braincancer resources 💛 These advocacy groups have a wealth of knowledge so please follow & share to #patients & #caregivers: (More can be found on our website:...

read more

Head for the Cure Texas

Come join us at the upcoming @HeadfortheCure 5K runs in San Antonio and Houston! It’s not too late to register as we join together in the fight against brain cancer. Plus Therapeutics will run (or walk) the races and have a booth on-site to provide education about our...

read more

ABTA National Conference

We’re excited to exhibit at the ABTA National Conference! Visit our booth to learn more about our latest advancements in #braintumor treatment and support. Join us: http://abta.org/national-conference #BTSM #BrainTumorAwareness

read more

Support Group Sessions

Mark your calendars! Our clinical and patient advocacy teams will be speaking at some upcoming @HeadfortheCure patient and caregiver events. Tune in to learn about Glioblastoma and our ongoing ReSPECT-GBM clinical trial. For more information and to sign up, click...

read more

Symposium Replay

Now Streaming: Replay the live symposium by Plus Therapeutics presented at the 2024 SNO/ASCO CNS Metastases Conference in Denver, CO. Watch on YouTube: https://youtu.be/kOWF7ym0WSE

read more

ReSPECT-LM Data from SNO/ASCO

Highlights include: > Respect-LM dosing shows continued feasibility and safety of up to 44 mCi of intrathecal Rhenium (186Re) Obisbemeda > High absorbed radiation doses, mean circulating tumor cell reductions, and median overall survival of 12 months continue to...

read more

SNO/ASCO Presentations

Attending SNO/ASCO CNS Conference in Denver this week? So are we! Read the full details on our upcoming symposium, oral presentations, and posters: https://bit.ly/3LFxFMS...

read more

SNO/ASCO Bronze Supporter

Plus Therapeutics is proud to be a Bronze Supporter and Exhibitor at the SNO / ASCO CNS Conference this year! Come by our booth, posters, and presentations we have going on throughout the conference. Detail including times and presentation titles:...

read more

SNO/ASCO Symposium

You're Invited to our symposium "Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases," presented at the SNO/ASCO CNS conference in Denver. More information & RSVP: https://bit.ly/4bM777e "Emerging Novel Diagnostic and Therapeutic...

read more

2024 SNO/ASCO Curtain Raiser

UPCOMING PRESENTATIONS: Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference and scheduled to present new data, highlighting progress in its therapeutics and diagnostics programs for Leptomeningeal Metastases Read the full details...

read more

Radiotherapeutics Q&A

"Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer. In RPT, radiation is systemically or locally delivered. To learn more about emerging developments, Digital Journal spoke with Marc Hedrick, MD...

read more

GBM Fight

"A lot of the battles that [GBM] picks are people that are truly going to fight back and give hope to the next patient..." ✊ Watch the full interview with Olympic Athlete & Brain Cancer Champion Scott Hamilton: https://bit.ly/4bKiufQ Social Media:...

read more

Gordon Research Conference

Join us at the Gordon Research Conference: Radionuclide Theranostics for the Management of Cancer, being held July 7-12 in Newry, Maine, as Plus Therapeutics takes the stage. Presentation by Melissa Moore, Ph.D. Press Release: https://bit.ly/PSTV_PR...

read more

GBMRO Podcast

We are proud to support @glioblastomaakagbm podcast by @glioblastomaresearch! Listen again to the episode "Power and Precision with Plus Therapeutics": https://spoti.fi/3W4O5Dl In their latest episode, they are joined by Holly Gainsboro, a grief specialist and founder...

read more

OSU for ReSPECT-LM

❗NEW CLINICAL TRIAL INVESTIGATION SITE❗ We are pleased to announce the addition of Ohio State University in Columbus, Ohio to our ReSPECT-LM Clinical Trial with Principal Investigator Shirley Ong M.D.. This site is NOW ENROLLING patients. Learn More about Dr. Ong:...

read more

Brain & Spine Metastasis Awareness Month

June is Brain & Spine Metastasis Awareness Month! 🧠🎗️ We want to continue to raise awareness for Leptomeningeal Metastases, which is diagnosed in approximately 110,000 cases per year in the U.S. Learn more about this metastatic cancer by visiting our Comprehensive...

read more

SNMMI Presentation for LM

Plus Therapeutics presented data on its novel radioisotope rhenium-186 at the annual meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI) in Toronto. Link to presentation: https://bit.ly/4bd9GyB An oral presentation titled, “Radiation Absorbed...

read more